5-HT2A/2C receptor signaling via phospholipase A2 and arachidonic acid is attenuated in mice lacking the serotonin reuptake transporter

被引:0
|
作者
Ying Qu
Nelly Villacreses
Dennis L. Murphy
Stanley I. Rapoport
机构
[1] National Institutes of Health,Brain Physiology and Metabolism Section, National Institute on Aging
[2] National Institutes of Health,Laboratory of Clinic Science, National Institute of Mental Health
[3] Johnson & Johnson Pharmaceutical Research and Development,Neuroscience, Drug Discovery
[4] L.L.C.,undefined
来源
Psychopharmacology | 2005年 / 180卷
关键词
Serotonin; Phospholipase A; Arachidonic acid; Signal transduction; Imaging; Brain; SERT; Knockout; DOI;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:12 / 20
页数:8
相关论文
共 50 条
  • [1] 5-HT2A/2C receptor signaling via phospholipase A2 and arachidonic acid is attenuated in mice lacking the serotonin reuptake transporter
    Qu, Y
    Villacreses, N
    Murphy, DL
    Rapoport, SI
    PSYCHOPHARMACOLOGY, 2005, 180 (01) : 12 - 20
  • [2] Adaptive changes of serotonin 5-HT2A receptors in mice lacking the serotonin transporter
    Rioux, A
    Fabre, V
    Lesch, KP
    Moessner, R
    Murphy, DL
    Lanfumey, L
    Hamon, M
    Martres, MP
    NEUROSCIENCE LETTERS, 1999, 262 (02) : 113 - 116
  • [3] Chronic lithium administration to rats selectively modifies 5-HT2A/2C receptor-mediated brain signaling via arachidonic acid
    Basselin, M
    Chang, L
    Seemann, R
    Bell, JM
    Rapoport, SI
    NEUROPSYCHOPHARMACOLOGY, 2005, 30 (03) : 461 - 472
  • [4] Chronic Lithium Administration to Rats Selectively Modifies 5-HT2A/2C Receptor-Mediated Brain Signaling Via Arachidonic Acid
    Mireille Basselin
    Lisa Chang
    Ruth Seemann
    Jane M Bell
    Stanley I Rapoport
    Neuropsychopharmacology, 2005, 30 : 461 - 472
  • [5] Fluvoxamine, a selective serotonin reuptake inhibitor, exerts its antiallodynic effects on neuropathic pain in mice via 5-HT2A/2C receptors
    Honda, Motoko
    Uchida, Kunitoshi
    Tanabe, Mitsuo
    Ono, Hideki
    NEUROPHARMACOLOGY, 2006, 51 (04) : 866 - 872
  • [6] Dibenzofuranylethylamines as 5-HT2A/2C Receptor Agonists
    Yempala, Thirumal
    Brea, Jose
    Isabel Loza, Maria
    Matthies, Douglas J.
    Zapata-Torres, Gerald
    Cassels, Bruce K.
    ACS OMEGA, 2020, 5 (05): : 2260 - 2266
  • [7] Role of 5-HT2A and 5-HT2B/2C Receptors in the Behavioral Interactions Between Serotonin and Catecholamine Reuptake Inhibitors
    Lance R McMahon
    Kathryn A Cunningham
    Neuropsychopharmacology, 2001, 24 : 319 - 329
  • [8] Role of 5-HT2A and 5-HT2B/2C receptors in the behavioral interactions between serotonin and catecholamine reuptake inhibitors
    McMahon, LR
    Cunningham, KA
    NEUROPSYCHOPHARMACOLOGY, 2001, 24 (03) : 319 - 329
  • [9] Mianserin, a 5-HT2a/2c and alpha(2) antagonist, in the treatment of sexual dysfunction induced by serotonin reuptake inhibitors
    Aizenberg, D
    Gur, S
    Zemishlany, Z
    Granek, M
    Jeczmien, P
    Weizman, A
    CLINICAL NEUROPHARMACOLOGY, 1997, 20 (03) : 210 - 214
  • [10] Alterations in small intestinal mucosa of mice lacking the serotonin reuptake transporter are 5HT2A receptor-dependent
    Gross, Erica Rachel
    Mazo, Ross E.
    Gertsberg, Zoya V.
    Gershon, Michael D.
    Cowles, Robert A.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2010, 211 (03) : S75 - S75